ArticleInternational journal of molecular sciences2024

Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.

Beynon Abrahams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.